108 related articles for article (PubMed ID: 21557977)
81. Utilizing Immunocytokines for Cancer Therapy.
Runbeck E; Crescioli S; Karagiannis SN; Papa S
Antibodies (Basel); 2021 Mar; 10(1):. PubMed ID: 33803078
[TBL] [Abstract][Full Text] [Related]
82. Vaccine Therapies for Cancer: Then and Now.
Morse MA; Gwin WR; Mitchell DA
Target Oncol; 2021 Mar; 16(2):121-152. PubMed ID: 33512679
[TBL] [Abstract][Full Text] [Related]
83. Targeting phosphatidylserine for Cancer therapy: prospects and challenges.
Chang W; Fa H; Xiao D; Wang J
Theranostics; 2020; 10(20):9214-9229. PubMed ID: 32802188
[TBL] [Abstract][Full Text] [Related]
84. Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model.
De M; Ghosh S; Asad M; Banerjee I; Ali N
Cancer Immunol Immunother; 2020 Sep; 69(9):1725-1735. PubMed ID: 32328672
[TBL] [Abstract][Full Text] [Related]
85. Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer.
Allahverdiyev A; Tari G; Bagirova M; Abamor ES
J Breast Cancer; 2018 Dec; 21(4):343-353. PubMed ID: 30607155
[TBL] [Abstract][Full Text] [Related]
86. Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site.
Kiefer JD; Neri D
Immunol Rev; 2016 Mar; 270(1):178-92. PubMed ID: 26864112
[TBL] [Abstract][Full Text] [Related]
87. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.
Blanco VM; Latif T; Chu Z; Qi X
Transl Oncol; 2015 Jun; 8(3):196-203. PubMed ID: 26055177
[TBL] [Abstract][Full Text] [Related]
88. Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virions.
Dowall SD; Graham VA; Corbin-Lickfett K; Empig C; Schlunegger K; Bruce CB; Easterbrook L; Hewson R
J Immunol Res; 2015; 2015():347903. PubMed ID: 25815346
[TBL] [Abstract][Full Text] [Related]
89. Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.
Nguyen ST; Nguyen HL; Pham VQ; Nguyen GT; Tran CD; Phan NK; Pham PV
Onco Targets Ther; 2015; 8():323-34. PubMed ID: 25674007
[TBL] [Abstract][Full Text] [Related]
90. Allogeneic tumor cell vaccines: the promise and limitations in clinical trials.
Srivatsan S; Patel JM; Bozeman EN; Imasuen IE; He S; Daniels D; Selvaraj P
Hum Vaccin Immunother; 2014; 10(1):52-63. PubMed ID: 24064957
[TBL] [Abstract][Full Text] [Related]
91. Formulation and evaluation of oral microparticulate ovarian cancer vaccines.
Tawde SA; Chablani L; Akalkotkar A; D'Souza C; Chiriva-Internati M; Selvaraj P; D'Souza MJ
Vaccine; 2012 Aug; 30(38):5675-81. PubMed ID: 22750042
[TBL] [Abstract][Full Text] [Related]
92. Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.
He J; Luster TA; Thorpe PE
Clin Cancer Res; 2007 Sep; 13(17):5211-8. PubMed ID: 17785577
[TBL] [Abstract][Full Text] [Related]
93. Nanopulse Stimulation (NPS) Induces Tumor Ablation and Immunity in Orthotopic 4T1 Mouse Breast Cancer: A Review.
Beebe SJ; Lassiter BP; Guo S
Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29601471
[TBL] [Abstract][Full Text] [Related]
94. Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer.
Belzile O; Huang X; Gong J; Carlson J; Schroit AJ; Brekken RA; Freimark BD
Immunotargets Ther; 2018; 7():1-14. PubMed ID: 29417044
[TBL] [Abstract][Full Text] [Related]
95. Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine.
Huang X; Ye D; Thorpe PE
Vaccine; 2011 Jun; 29(29-30):4785-93. PubMed ID: 21557977
[TBL] [Abstract][Full Text] [Related]
96. Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells.
Yang X; Chu Y; Wang Y; Guo Q; Xiong S
Vaccine; 2006 Apr; 24(15):2966-74. PubMed ID: 16503368
[TBL] [Abstract][Full Text] [Related]
97. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
Rodolfo M; Zilocchi C; Melani C; Cappetti B; Arioli I; Parmiani G; Colombo MP
J Immunol; 1996 Dec; 157(12):5536-42. PubMed ID: 8955204
[TBL] [Abstract][Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
